Annual report pursuant to Section 13 and 15(d)

Intangibles - Additional Information (Detail)

v3.20.1
Intangibles - Additional Information (Detail) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jul. 22, 2019
Jan. 31, 2016
Mar. 31, 2015
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Indefinite-lived Intangible Assets [Line Items]            
Intangible asset, net       $ 7,377,000 $ 1,417,000  
Purchase of intangible asset       2,400,000 1,200,000  
Journey Medical Corporation [Member]            
Indefinite-lived Intangible Assets [Line Items]            
Intangible asset, net       7,377,000 $ 1,417,000 $ 883,000
Journey Medical Corporation [Member] | Luxamend [Member]            
Indefinite-lived Intangible Assets [Line Items]            
Purchase of intangible asset   $ 50,000        
Journey Medical Corporation [Member] | Ceracade [Member]            
Indefinite-lived Intangible Assets [Line Items]            
Purchase of intangible asset           $ 300,000
Journey Medical Corporation [Member] | Targadox [Member]            
Indefinite-lived Intangible Assets [Line Items]            
Purchase of intangible asset     $ 1,300,000      
Journey Medical Corporation [Member] | Exelderm            
Indefinite-lived Intangible Assets [Line Items]            
Intangible asset, net       667,000    
Ximino            
Indefinite-lived Intangible Assets [Line Items]            
Total consideration $ 9,400,000          
Upfront payment $ 2,400,000          
Upfront payment period 60 days          
Intangible asset, net       $ 7,100,000    
Remaining payment due on second anniversary of execution $ 7,000,000          
Initial discount for imputed interest $ 2,300,000